In another study of 30 NAFLD patients with elevated liver enzymes, obesity and type 2 DM, exenatide plus insulin was seen to improve steatosis from baseline in 28 (93.3%) patients, which was a significantly higher improvement rate than that observed with intensive insulin therapy24. The gene discussed is INS; the disease is obesity disorder.